Portrait of the use of carbapenemics in a hospital belonging to the unified health system

Detalhes bibliográficos
Autor(a) principal: Cândido, Suzany Helena da Silva
Data de Publicação: 2022
Outros Autores: Vidal, Marlessa Danielle Assis, Oliveira, Sandra Barros de, Badin, Rebeka Caribé
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/31647
Resumo: Antimicrobials are an important therapeutic arsenal against graves, as they have broad-spectrum bactericidal activities and better stability against βlactamases. This group of antimicrobials acts against gram-positive and gram-negative, aerobic and aerobic bacteria, and mainly in nosocomial infections. However, the presence of carbapenemases constitutes one of the main mechanisms of resistance. This article aims to identify the profile of patients who used carbapenem antimicrobials and quantify the consumption of this class based on the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) methodology in a high-complexity hospital in the year 2020. This is an observational and retrospective study in a hospital belonging to the Unified Health System (SUS). Data collection was performed based on medical records, prescriptions, and antimicrobial control forms. A total of 120 patients were included in the study, the mean age was 52 ± 17.58 years, and the mean length of stay in the hospital was 33 ± 29.68 days. Carbapenem requests were analyzed, of which 74% were meropenem, 21% imipenem + cilastatin, and 5% ertapenem. The most consumed carbapenem during the study period was meropenem (DDD 252.87). Our findings made it possible to trace the profile of use of drugs belonging to the class of carbapenems in the high complexity hospital, demonstrating their importance, especially in the treatment of critically ill patients.
id UNIFEI_6bf507b4a05f967d859921d3cd399c9b
oai_identifier_str oai:ojs.pkp.sfu.ca:article/31647
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Portrait of the use of carbapenemics in a hospital belonging to the unified health systemRetrato del uso de carbapenémicos en un hospital perteneciente al sistema único de saludRetrato do uso de carbapenêmicos em um hospital pertencente ao sistema único de saúdeCarbapenemsRational useBacterial resistance.CarbapenémicosUso racionalResistencia bacteriana.CarbapenêmicosUso racionalResistência bacteriana.Antimicrobials are an important therapeutic arsenal against graves, as they have broad-spectrum bactericidal activities and better stability against βlactamases. This group of antimicrobials acts against gram-positive and gram-negative, aerobic and aerobic bacteria, and mainly in nosocomial infections. However, the presence of carbapenemases constitutes one of the main mechanisms of resistance. This article aims to identify the profile of patients who used carbapenem antimicrobials and quantify the consumption of this class based on the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) methodology in a high-complexity hospital in the year 2020. This is an observational and retrospective study in a hospital belonging to the Unified Health System (SUS). Data collection was performed based on medical records, prescriptions, and antimicrobial control forms. A total of 120 patients were included in the study, the mean age was 52 ± 17.58 years, and the mean length of stay in the hospital was 33 ± 29.68 days. Carbapenem requests were analyzed, of which 74% were meropenem, 21% imipenem + cilastatin, and 5% ertapenem. The most consumed carbapenem during the study period was meropenem (DDD 252.87). Our findings made it possible to trace the profile of use of drugs belonging to the class of carbapenems in the high complexity hospital, demonstrating their importance, especially in the treatment of critically ill patients.Los antimicrobianos carbapenémicos constituyen un importante arsenal terapéutico contra infecciones graves, ya que poseen actividades bactericidas de amplio espectro y mejor estabilidad frente a las β-lactamasas. Este grupo de antimicrobianos actúa contra bacterias grampositivas y gramnegativas, aerobias y anaerobias y principalmente en infecciones nosocomiales. Sin embargo, la presencia de carbapanemasas constituye uno de los principales mecanismos de resistencia. El objetivo de este trabajo es identificar el perfil de pacientes que usaron antimicrobianos carbapenémicos y cuantificar el consumo de esta clase con base en la metodología Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) en un hospital de alta complejidad en el año 2020. Se trata de un estudio observacional y retrospectivo en un hospital perteneciente al Sistema Único de Salud (SUS). La recolección de datos se realizó con base en historias clínicas, recetas médicas y formularios de control de antimicrobianos. Se incluyeron en el estudio un total de 120 pacientes, la edad media fue de 52 ± 17,58 años y la estancia media hospitalaria fue de 33 ± 29,68 días. Se analizaron las solicitudes de carbapenem, de las cuales el 74% fueron meropenem, el 21% imipenem + cilastatina y el 5% ertapenem. El carbapenem más consumido durante el período de estudio fue el meropenem (DDD 252,87). Nuestros hallazgos permitieron trazar el perfil de uso de medicamentos pertenecientes a la clase de los carbapenémicos en el hospital de alta complejidad, demostrando su importancia, especialmente en el tratamiento de pacientes críticos.Os antimicrobianos carbapenêmicos constituem um importante arsenal terapêutico contra infecções graves, pois apresentam atividades bactericidas de amplo espectro e melhor estabilidade contra β-lactamases. Este grupo de antimicrobianos atua contra bactérias gram-positivas e gram-negativas, aeróbias e anaeróbias e principalmente em infecções hospitalares. Entretanto, a presença de carbapanemases constitui um dos principais mecanismos de resistência. O objetivo desse trabalho é identificar o perfil dos pacientes que utilizaram os antimicrobianos carbapenêmicos e quantificar o consumo dessa classe tendo como base a metodologia da Anatomical Therapeutic Chemical/Dose Diária Definida (ATC/DDD) em um hospital de alta complexidade no ano de 2020. Trata-se de um estudo observacional e retrospectivo, em um hospital pertencente ao Sistema Único de Saúde (SUS). A coleta de dados foi realizada com base nos prontuários, prescrições médicas e nos formulários de controle de antimicrobianos. Ao total 120 pacientes foram incluídos no estudo, a média de idade foi de 52 ± 17,58 anos e o tempo médio de permanência na unidade hospitalar foi de 33 ± 29,68 dias. Foram analisadas as solicitações de carbapenêmicos, destes 74% eram meropenem, 21% imipenem + cilastatina e 5% ertapenem. O carbapenêmico mais consumido no período do estudo foi o meropenem (DDD 252,87). Nossos achados possibilitaram traçar o perfil de utilização dos medicamentos pertencentes à classe dos carbapenêmicos no hospital de alta complexidade, demonstrando a importância dos mesmos, principalmente no tratamento de pacientes críticos.Research, Society and Development2022-07-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3164710.33448/rsd-v11i9.31647Research, Society and Development; Vol. 11 No. 9; e16811931647Research, Society and Development; Vol. 11 Núm. 9; e16811931647Research, Society and Development; v. 11 n. 9; e168119316472525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/31647/27025Copyright (c) 2022 Suzany Helena da Silva Cândido; Marlessa Danielle Assis Vidal; Sandra Barros de Oliveira; Rebeka Caribé Badinhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCândido, Suzany Helena da Silva Vidal, Marlessa Danielle Assis Oliveira, Sandra Barros de Badin, Rebeka Caribé2022-07-21T12:36:16Zoai:ojs.pkp.sfu.ca:article/31647Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:47:54.806509Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Portrait of the use of carbapenemics in a hospital belonging to the unified health system
Retrato del uso de carbapenémicos en un hospital perteneciente al sistema único de salud
Retrato do uso de carbapenêmicos em um hospital pertencente ao sistema único de saúde
title Portrait of the use of carbapenemics in a hospital belonging to the unified health system
spellingShingle Portrait of the use of carbapenemics in a hospital belonging to the unified health system
Cândido, Suzany Helena da Silva
Carbapenems
Rational use
Bacterial resistance.
Carbapenémicos
Uso racional
Resistencia bacteriana.
Carbapenêmicos
Uso racional
Resistência bacteriana.
title_short Portrait of the use of carbapenemics in a hospital belonging to the unified health system
title_full Portrait of the use of carbapenemics in a hospital belonging to the unified health system
title_fullStr Portrait of the use of carbapenemics in a hospital belonging to the unified health system
title_full_unstemmed Portrait of the use of carbapenemics in a hospital belonging to the unified health system
title_sort Portrait of the use of carbapenemics in a hospital belonging to the unified health system
author Cândido, Suzany Helena da Silva
author_facet Cândido, Suzany Helena da Silva
Vidal, Marlessa Danielle Assis
Oliveira, Sandra Barros de
Badin, Rebeka Caribé
author_role author
author2 Vidal, Marlessa Danielle Assis
Oliveira, Sandra Barros de
Badin, Rebeka Caribé
author2_role author
author
author
dc.contributor.author.fl_str_mv Cândido, Suzany Helena da Silva
Vidal, Marlessa Danielle Assis
Oliveira, Sandra Barros de
Badin, Rebeka Caribé
dc.subject.por.fl_str_mv Carbapenems
Rational use
Bacterial resistance.
Carbapenémicos
Uso racional
Resistencia bacteriana.
Carbapenêmicos
Uso racional
Resistência bacteriana.
topic Carbapenems
Rational use
Bacterial resistance.
Carbapenémicos
Uso racional
Resistencia bacteriana.
Carbapenêmicos
Uso racional
Resistência bacteriana.
description Antimicrobials are an important therapeutic arsenal against graves, as they have broad-spectrum bactericidal activities and better stability against βlactamases. This group of antimicrobials acts against gram-positive and gram-negative, aerobic and aerobic bacteria, and mainly in nosocomial infections. However, the presence of carbapenemases constitutes one of the main mechanisms of resistance. This article aims to identify the profile of patients who used carbapenem antimicrobials and quantify the consumption of this class based on the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) methodology in a high-complexity hospital in the year 2020. This is an observational and retrospective study in a hospital belonging to the Unified Health System (SUS). Data collection was performed based on medical records, prescriptions, and antimicrobial control forms. A total of 120 patients were included in the study, the mean age was 52 ± 17.58 years, and the mean length of stay in the hospital was 33 ± 29.68 days. Carbapenem requests were analyzed, of which 74% were meropenem, 21% imipenem + cilastatin, and 5% ertapenem. The most consumed carbapenem during the study period was meropenem (DDD 252.87). Our findings made it possible to trace the profile of use of drugs belonging to the class of carbapenems in the high complexity hospital, demonstrating their importance, especially in the treatment of critically ill patients.
publishDate 2022
dc.date.none.fl_str_mv 2022-07-06
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/31647
10.33448/rsd-v11i9.31647
url https://rsdjournal.org/index.php/rsd/article/view/31647
identifier_str_mv 10.33448/rsd-v11i9.31647
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/31647/27025
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 9; e16811931647
Research, Society and Development; Vol. 11 Núm. 9; e16811931647
Research, Society and Development; v. 11 n. 9; e16811931647
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052826729316352